An erythropoietin test measures the amount of a kidney hormone circulating in your blood, and that single number can explain why your red blood cell count is too low, too high, or drifting in a direction nobody expected. Erythropoietin, usually shortened to EPO, is the signal your kidneys send to your bone marrow when oxygen delivery starts to fall short. Because that signal sits upstream of red cell production, the result is most useful when it is read next to your hemoglobin and hematocrit rather than on its own. In this article you will learn what the test measures, why a doctor orders it, how to interpret the four common result patterns, which tests are usually run alongside it, and what recent research says about EPO in kidney disease and blood disorders.
What an erythropoietin test measures
Erythropoietin is a hormone produced mainly by specialized cells in the kidneys, with a small contribution from the liver. These cells act as oxygen sensors. When the oxygen carried in the blood drops, they release more EPO, which travels to the bone marrow and instructs it to produce additional red blood cells. When oxygen delivery is comfortable, EPO production quiets down. The system behaves like a thermostat rather than a switch.
A laboratory measures EPO in a serum sample, usually reported in milliunits per milliliter (mU/mL). According to Cleveland Clinic, a typical adult reference range sits somewhere around 4 to 26 mU/mL, though every laboratory sets its own interval based on the assay it uses. This is one of the reasons two reports with different numbers can both be normal: always read the range printed on your own report rather than a range quoted elsewhere.
The test does not measure how many red blood cells you have. That job belongs to a full blood panel, and you can review what those numbers mean by reading our complete blood count results guide. An EPO measurement answers a different question: is the production signal appropriate for the number of red cells currently in circulation?
Why doctors order an erythropoietin test
EPO is not part of a routine checkup. It is a second-line test, ordered once a standard blood panel has already shown something unusual. Three situations account for most requests.
The first is unexplained anemia. When hemoglobin is low and the usual causes have been ruled out, an EPO level helps separate a marrow that is not receiving enough signal from a marrow that is receiving plenty of signal but cannot act on it. If you want the underlying condition explained in plain terms, consult our guide to anemia symptoms and causes.
The second is a red cell count that is too high. Doctors call this erythrocytosis or polycythemia. An EPO level is one of the first steps in working out whether the bone marrow is overproducing on its own or responding correctly to a genuine oxygen shortage.
The third is kidney disease. Damaged kidneys gradually lose the ability to produce EPO, and the National Institute of Diabetes and Digestive and Kidney Diseases notes that anemia becomes more common as kidney function declines. If your report also shows reduced filtration, it is worth checking our eGFR blood test results guide and our creatinine test results guide, since both describe how kidney function is estimated.
Less often, an EPO test is used to monitor people already receiving erythropoiesis-stimulating agents, or to investigate a suspected hormone-producing tumor.
How the test is done and what can shift your result
The procedure is a standard venous blood draw, usually from the inside of the elbow, taking only a few minutes. Most laboratories ask for an early morning sample, and some request a short fast, mainly because EPO follows a mild daily rhythm and morning sampling keeps results comparable between visits. Follow whatever instructions your ordering clinician gives, since protocols differ between labs.
Several everyday factors move the number without any disease being present. Living or training at altitude raises EPO because the air holds less oxygen. Pregnancy raises it modestly. Recent heavy bleeding raises it as the body tries to rebuild. Smoking, untreated sleep apnea, and chronic lung conditions all push it upward for the same reason: the oxygen sensors in the kidneys perceive a shortfall. Conversely, inflammation, some cancers, and advanced kidney disease blunt the response.
Timing matters too. An EPO level drawn immediately after a transfusion, or during an acute illness, reflects that moment rather than your baseline. If the result looks surprising, a repeat sample taken under calmer conditions is often more informative than a single reading.
How to read your erythropoietin result
An EPO value in isolation says very little. Its meaning comes from the pairing between the hormone level and the red cell measurements taken at the same time. Compare it first against our hemoglobin blood test guide and our hematocrit test results guide, then use the four patterns below.
| EPO level | Red blood cell count | What the pattern usually suggests |
|---|---|---|
| High | Low | The signal is working, but the marrow cannot deliver: iron deficiency, ongoing blood loss, vitamin shortage, or a marrow disorder |
| Low or low-normal | Low | The kidneys are not producing enough hormone; chronic kidney disease is the classic explanation |
| Below the reference range | High | Points toward polycythemia vera, a bone marrow condition that drives production from within |
| Normal or high | High | Secondary erythrocytosis: low oxygen from lung disease, sleep apnea, altitude, smoking, testosterone therapy, or rarely a hormone-producing tumor |
High EPO with a low red cell count
This is the most common abnormal pattern and usually the least alarming. The kidneys have noticed the anemia and are calling for reinforcements. The bottleneck lies further down the line, most often in the raw materials. Iron is the usual suspect, which is why a low iron store is checked early with our ferritin blood level guide.
Low EPO with a low red cell count
Here the signal itself is missing. Reduced kidney function is by far the leading cause, and the anemia typically develops slowly as filtration declines. Our chronic kidney disease overview explains how that progression is staged and monitored.
Subnormal EPO with a high red cell count
When the marrow produces red cells despite the hormone being switched down, the drive is coming from inside the marrow. This pattern raises the possibility of polycythemia vera and normally leads to genetic testing. Mayo Clinic describes blood tests, bone marrow sampling, and gene analysis as the standard workup for that diagnosis.
Normal or high EPO with a high red cell count
The marrow is doing exactly what it was told. The task then becomes finding the source of the oxygen shortfall, which may be a lung condition, untreated sleep apnea, heavy smoking, life at altitude, or a medication. Checking how efficiently new cells are being released can help, and you can interpret that step with our reticulocyte count results guide.
Conditions linked to abnormal erythropoietin levels
Low EPO is dominated by kidney disease, but it also appears in some chronic inflammatory conditions and in certain marrow disorders. High EPO covers a much wider territory: iron deficiency anemia, blood loss, high-altitude living, chronic lung disease, obstructive sleep apnea, heart conditions that reduce oxygen delivery, and occasionally tumors of the kidney or liver that manufacture the hormone independently.
Medications matter as well. Testosterone therapy and some diabetes medicines raise red cell counts, and erythropoiesis-stimulating agents given for kidney-related anemia will directly change what an EPO measurement shows. Always tell the laboratory and your clinician what you are taking, since an unexplained result is often explained by the medication list.
Persistent tiredness is the symptom that brings most people to this test in the first place, though fatigue has many causes that have nothing to do with red cells; our chronic fatigue syndrome guide covers several of them.
Tests usually ordered alongside an EPO measurement
An erythropoietin result is rarely interpreted alone. The panel below shows what each companion test adds to the picture.
| Test | What it adds |
|---|---|
| Complete blood count | Establishes whether red cells are low, normal, or high, and screens the other cell lines |
| Hemoglobin and hematocrit | Quantifies oxygen-carrying capacity and the proportion of blood made up of red cells |
| Reticulocyte count | Shows whether the marrow is actively releasing new red cells right now |
| Ferritin and transferrin saturation | Reveals whether iron stores and iron transport can support red cell production |
| Creatinine and eGFR | Estimates kidney function, the organ that makes most of your erythropoietin |
| JAK2 genetic testing | Looks for the gene change associated with polycythemia vera when red cells are high |
| Oxygen saturation | Identifies a breathing or circulation problem that could justify a high hormone level |
Iron transport deserves particular attention when EPO is high and hemoglobin is low, and our transferrin saturation test guide explains how that measurement is calculated.
When to see a doctor about your result
An EPO number outside the reference range is a reason for a conversation, not for alarm. Book an appointment promptly if your result is abnormal and you also have shortness of breath at rest, chest discomfort, unusual bruising, dizziness, or fatigue that has changed noticeably over weeks rather than months.
Seek care sooner if a high red cell count is accompanied by headaches, blurred vision, redness of the face, or itching after a hot shower, since those symptoms are associated with thickened blood. If a low result comes alongside declining kidney numbers, ask whether iron status and vitamin levels have been checked, because these are correctable contributors that are easy to overlook.
Bring your full report to the appointment rather than the single EPO value. Trends over time carry more weight than any isolated reading, and a clinician comparing several panels can often resolve in minutes a question that a single number leaves open.
Latest scientific advances
Research on erythropoietin over the past three years has moved in two directions: sharpening how the test is interpreted, and rethinking how the hormone pathway is treated.
On interpretation, a 2024 study published in Diagnostics compared several different cutoffs used to call an EPO level abnormally low, testing them in people with high red cell counts. What it found is that the threshold you choose changes the answer: a stricter cutoff catches fewer cases but is more reliable when it does, while a more generous one catches almost everyone with polycythemia vera at the cost of flagging many people who do not have it. What this means for you is simple: if your EPO sits just below or just above the printed range, that borderline number is not a verdict, and your clinician will weigh it alongside genetic and marrow findings rather than treating it as decisive.
A 2025 expert review in the American Journal of Hematology reached a similar conclusion from the clinical side. Updating guidance on high red cell counts that are not caused by the usual gene change, the authors describe serum erythropoietin as variably informative, and highlight that some newer diabetes medicines are an increasingly recognized cause of raised red cell counts. What this means for you is that a full medication list is now part of the workup, and that a normal EPO level does not close the investigation.
On treatment, a class of oral medicines known as HIF prolyl hydroxylase inhibitors has been developed to nudge the body into making its own erythropoietin, as an alternative to injections for anemia caused by kidney disease. A 2024 systematic review in NEJM Evidence pooled twenty-five trials with more than twenty-six thousand participants followed for at least a year and found no signal that these tablets carry a different long-term heart risk than the established injectable treatments. An earlier 2023 pooled analysis in Renal Failure reported that they raised hemoglobin effectively in people not yet on dialysis and also improved iron handling. Both remain areas of active study rather than settled consensus, and a 2024 review in Renal Failure focused on one of these drugs noted that blood pressure and potassium still need monitoring. What this means for you is that if you live with kidney-related anemia, an oral option may now be part of the discussion with your nephrologist, alongside iron and the older injections.
None of this changes the basics. An EPO test is still a supporting measurement that gains its meaning from the company it keeps.
Glossary
| Term | Definition |
|---|---|
| Erythropoietin (EPO) | A hormone made mainly by the kidneys that tells the bone marrow to produce red blood cells. |
| Erythropoiesis | The process of making new red blood cells in the bone marrow. |
| Hematocrit | The percentage of your blood volume made up of red blood cells. |
| Erythrocytosis | A red blood cell count above the expected range, also called polycythemia. |
| Polycythemia vera | A bone marrow disorder in which red cells are overproduced independently of the hormone signal. |
| Reticulocyte | A young red blood cell recently released by the marrow; a marker of production activity. |
| Erythropoiesis-stimulating agent (ESA) | An injectable medicine that mimics erythropoietin, used mainly in kidney-related anemia. |
| Reference range | The interval of values a laboratory considers typical, based on the method it uses. |
| Serum | The clear liquid part of blood left after clotting, used for many hormone measurements. |
| JAK2 | A gene whose alteration is commonly found in polycythemia vera and related conditions. |
Frequently asked questions
What is a normal EPO blood test range?
Most adult laboratories report a range in the region of 4 to 26 mU/mL, but the interval printed on your own report is the one that applies. Assays differ between laboratories, so a value that is normal on one report can sit slightly outside the range on another. Age, sex, altitude, and current hemoglobin all influence where a healthy person falls within that band, which is why the number is interpreted alongside a blood count rather than on its own.
What does a high erythropoietin level mean?
A high level usually means the body senses that oxygen delivery is insufficient and is asking for more red blood cells. The most frequent explanations are anemia, blood loss, living at altitude, chronic lung disease, and untreated sleep apnea. Rarely, a tumor of the kidney or liver produces the hormone on its own. The interpretation depends heavily on whether your red cell count is low or high at the same time.
What causes a low erythropoietin level?
The dominant cause is reduced kidney function, since the kidneys make most of the hormone. Some chronic inflammatory conditions also suppress production. A level below the reference range in someone whose red cell count is high points in a different direction entirely, toward a bone marrow condition such as polycythemia vera, and normally prompts genetic testing.
Do I need to fast before an erythropoietin test?
Many laboratories request a morning sample and some ask for a short fast, mainly to keep results comparable between visits rather than because food changes the hormone dramatically. Follow the instruction given with your requisition. If you take testosterone, iron, or medicines that affect red cell production, mention them when the sample is collected, since they can shift the result.
Can exercise or altitude change my EPO result?
Yes. Spending time at altitude reliably raises erythropoietin because the air contains less oxygen, and the effect can persist for weeks after returning to sea level. Intense endurance training has a smaller and shorter-lived effect. Neither is a disease, but both are worth mentioning to whoever interprets your result, because an unexplained high value often has a straightforward environmental explanation.
Is the EPO test used to detect doping?
Anti-doping programs do test for synthetic erythropoietin, but they use specialized methods that distinguish manufactured hormone from the kind your body makes, along with long-term monitoring of blood values. A standard clinical EPO measurement ordered by your doctor is not designed for that purpose and is not interpreted that way.
Sources
- Cleveland Clinic — Erythropoietin: Production, Purpose, Test and Levels — Health Library, reviewed 2025 — my.clevelandclinic.org
- National Institute of Diabetes and Digestive and Kidney Diseases — Anemia in Chronic Kidney Disease — NIDDK Health Information — niddk.nih.gov
- Mayo Clinic — Polycythemia Vera: Diagnosis and Treatment — Mayo Clinic Patient Care and Health Information — mayoclinic.org
- Yoon JS, Kang H, Jekarl DW, Lee SE, Oh EJ — Diagnostic Performance of Serum Erythropoietin to Discriminate Polycythemia Vera from Secondary Erythrocytosis through Established Subnormal Limits — Diagnostics, 2024 — doi.org/10.3390/diagnostics14171902
- Gangat N, Szuber N, Tefferi A — JAK2 Unmutated Erythrocytosis: 2026 Update on Diagnosis and Management — American Journal of Hematology, 2025 — doi.org/10.1002/ajh.70118
- Ha JT, Hiremath S, Jun M, Green SC, Wheeler DC, Coyne DW, Perkovic V, Badve SV — Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors in Kidney Disease — NEJM Evidence, 2024 — doi.org/10.1056/EVIDoa2300189
- Zhao H, Li P, Zhang HL, Jia L — An updated meta-analysis on the efficacy and safety of hypoxia-inducible factor prolyl hydroxylase inhibitor treatment of anemia in nondialysis-dependent chronic kidney disease — Renal Failure, 2023 — doi.org/10.1080/0886022X.2023.2258986
- Tian L, Wang M, Liu M, Pang Y, Zhao J, Zheng B, Wang Y, Zhao W — Cardiovascular and renal safety outcomes of hypoxia-inducible factor prolyl-hydroxylase inhibitor roxadustat for anemia patients with chronic kidney disease: a systematic review and meta-analysis — Renal Failure, 2024 — doi.org/10.1080/0886022X.2024.2313864
Further reading
- Check the size of your red blood cells by reading our mean corpuscular volume results guide.
- Explore how much your red cells vary in size with our red cell distribution width results guide.
- Assess kidney function beyond creatinine using our cystatin C blood level guide.
- Rule out a vitamin cause of anemia by consulting our vitamin B12 levels guide.
- Understand a common marker of inflammation through our erythrocyte sedimentation rate results guide.
Understand your lab results with BloodSense
An erythropoietin result only makes sense next to your red cell count, your iron status, and your kidney numbers, which is exactly the kind of cross-reading that takes time to do by hand. BloodSense reads your full report and explains how EPO, hemoglobin, ferritin, and creatinine fit together in plain language. It helps you understand what your panel shows and which questions are worth raising, without diagnosing anything or replacing your doctor.
